KC
EW icon

Kepos Capital’s Edwards Lifesciences EW Stock Holding History

Kepos Capital’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-9,822
Closed -$764K – 212
2019
Q4 		$764K Buy
+9,822
New +$767K 0.07% 171
2019
Q3 		– Sell
-43,605
Closed -$2.69M – 340
2019
Q2 		$2.69M Buy
+43,605
New +$2.64M 0.27% 75
2018
Q4 		– Sell
-116,928
Closed -$6.79M – 363
2018
Q3 		$6.79M Sell
116,928
-849
-0.7% -$41.5K 0.35% 46
2018
Q2 		$5.71M Buy
117,777
+92,622
+368% +$4.32M 0.29% 79
2018
Q1 		$1.17M Hold
25,155
– – 0.07% 167
2017
Q4 		$945K Buy
+25,155
New +$923K 0.09% 144

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Kepos Capital's EW Position: Q1 2020 in Review

Kepos Capital sold out of Edwards Lifesciences (EW) in Q1 2020, closing a stake of 9,822 shares — an estimated $764K sold.

Kepos Capital first reported a position in EW in Q4 2017 and held it in 6 quarters. The position peaked at $6.79M in Q3 2018. 1,019 funds tracked by Wall St. Rank hold EW as of Q1 2020.

  • Kepos Capital reported no remaining Edwards Lifesciences position as of Q1 2020 after selling out during the quarter.
  • Kepos Capital sold 9,822 Edwards Lifesciences shares in Q1 2020, an estimated $764K.
  • Kepos Capital first reported a position in Edwards Lifesciences in Q4 2017 and held it in 6 quarters.
  • Kepos Capital's Edwards Lifesciences position peaked at $6.79M in Q3 2018.
  • 1,019 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2020.

Based on Kepos Capital's 13F filing for Q1 2020, filed 12 May 2020.